Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients.

María Martínez-UrbistondoÁngela Gutiérrez-RojasAne AndrésIsabel GutiérrezGabriela EscuderoSonia GarcíaAndrea GutiérrezEnrique SánchezJesús HerráizSara De La FuenteAlejandro CallejasCarmen De MendozaVíctor Moreno-Torres

Published in: Journal of clinical medicine (2021)

Immunosuppression is an independent mortality risk factor in COVID-19. Severe lymphopenia should be promptly identified in these patients.

Keyphrases

end stage renal disease
coronavirus disease
newly diagnosed
sars cov
chronic kidney disease
risk factors
peritoneal dialysis
prognostic factors
cardiovascular events
cardiovascular disease
patient reported outcomes